- A/California/7/2009 (H1N1)pdm09-like virus
- A/Victoria/36/2011 (H3N2)-like virus
- B/Wisconsin/1/2010-like virus (from the B/Yamagata lineage of viruses)
A series of clinical trials will test the combination of Bristol-Myers Squibb's Opdivo with Nektar's NKTR-214 in multiple tumor types.
The company has spent $600 million weighing a potential breakup.
Jefferies increased AstraZeneca's (AZN) stock rating to 'buy' this morning.